<p>Aligos Therapeutics Inc. has granted non-qualified stock options to purchase a total of 81,100 shares to newly hired employees, effective January 29, 2026. The options were issued under the company’s 2024 Inducement Plan. Each grant has an exercise price set at the closing price of Aligos’ common stock on the grant date. Vesting will occur over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9645757-en) on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

ALGS

SBIO

ARKG

Reuters

Aligos Therapeutics

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

SPDR S&P Biotech

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

Aligos Therapeutics Grants Stock Options to New Employees Under 2024 Inducement Plan